Despite no earnings, Blueprint Medicines (NASDAQ:BPMC) appears to be above its debt
David Iben said it well when he said: “Volatility is not a risk that interests us. What matters to us is to avoid the permanent loss of capital. So it may be obvious that you need to take debt into account when thinking about the risk of a given stock, because too much debt can …
Despite no earnings, Blueprint Medicines (NASDAQ:BPMC) appears to be above its debt Read More »